Caseware UK (AP4) 2023.0.135 2023.0.135 2023-10-312023-10-312022-11-01falseNo description of principal activity22falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 12967588 2022-11-01 2023-10-31 12967588 2021-11-01 2022-10-31 12967588 2023-10-31 12967588 2022-10-31 12967588 c:Director1 2022-11-01 2023-10-31 12967588 d:OfficeEquipment 2022-11-01 2023-10-31 12967588 d:OfficeEquipment 2023-10-31 12967588 d:OfficeEquipment 2022-10-31 12967588 d:OfficeEquipment d:OwnedOrFreeholdAssets 2022-11-01 2023-10-31 12967588 d:CurrentFinancialInstruments 2023-10-31 12967588 d:CurrentFinancialInstruments 2022-10-31 12967588 d:CurrentFinancialInstruments d:WithinOneYear 2023-10-31 12967588 d:CurrentFinancialInstruments d:WithinOneYear 2022-10-31 12967588 d:ShareCapital 2023-10-31 12967588 d:ShareCapital 2022-10-31 12967588 d:RetainedEarningsAccumulatedLosses 2023-10-31 12967588 d:RetainedEarningsAccumulatedLosses 2022-10-31 12967588 c:OrdinaryShareClass1 2022-11-01 2023-10-31 12967588 c:OrdinaryShareClass1 2023-10-31 12967588 c:OrdinaryShareClass2 2022-11-01 2023-10-31 12967588 c:OrdinaryShareClass2 2023-10-31 12967588 c:OrdinaryShareClass3 2022-11-01 2023-10-31 12967588 c:OrdinaryShareClass3 2023-10-31 12967588 c:OrdinaryShareClass4 2022-11-01 2023-10-31 12967588 c:OrdinaryShareClass4 2023-10-31 12967588 c:OrdinaryShareClass5 2022-11-01 2023-10-31 12967588 c:OrdinaryShareClass5 2023-10-31 12967588 c:FRS102 2022-11-01 2023-10-31 12967588 c:AuditExempt-NoAccountantsReport 2022-11-01 2023-10-31 12967588 c:FullAccounts 2022-11-01 2023-10-31 12967588 c:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 12967588 d:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2022-11-01 2023-10-31 12967588 d:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-10-31 12967588 2 2022-11-01 2023-10-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 12967588









GKO MEDICAL LIMITED







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 OCTOBER 2023

 
GKO MEDICAL LIMITED
REGISTERED NUMBER: 12967588

BALANCE SHEET
AS AT 31 OCTOBER 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 4 
306
614

  
306
614

Current assets
  

Stocks
  
3,156
2,567

Debtors: amounts falling due within one year
 5 
326,840
205,742

Cash at bank and in hand
  
87,842
114,235

  
417,838
322,544

Creditors: amounts falling due within one year
 6 
(35,400)
(44,784)

Net current assets
  
 
 
382,438
 
 
277,760

Total assets less current liabilities
  
382,744
278,374

Provisions for liabilities
  

Deferred tax
  
(76)
(154)

  
 
 
(76)
 
 
(154)

Net assets
  
382,668
278,220


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
382,568
278,120

  
382,668
278,220


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

Page 1

 
GKO MEDICAL LIMITED
REGISTERED NUMBER: 12967588
    
BALANCE SHEET (CONTINUED)
AS AT 31 OCTOBER 2023

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 12 March 2024.




G Koehler
Director

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
GKO MEDICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023

1.


General information

The company is a United Kingdom company limited by shares. It is both incorporated and domiciled in England and Wales. The address of its registered office is 7 The Close, Norwich, NR1 4DJ.
The principal activity of the company is the provision of medical services. The company's principal place of business is Norwich, Norfolk.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Page 3

 
GKO MEDICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023

2.Accounting policies (continued)

 
2.5

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.6

Current and deferred taxation

The tax expense for the year comprises current and deferred tax.
Deferred tax balances are recognised in respect of timing differences that have originated but not reversed by the balance sheet date.
Current and deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

 
2.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
25%
Straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.8

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

Page 4

 
GKO MEDICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023

2.Accounting policies (continued)

 
2.9

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.10

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.11

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.12

Provisions for liabilities

Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to profit or loss in the year that the Company becomes aware of the obligation, and are measured at the best estimate at the balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the Balance sheet.

 
2.13

Financial instruments

The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

 
2.14

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2022 - 2).

Page 5

 
GKO MEDICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023

4.


Tangible fixed assets





Office equipment

£



Cost or valuation


At 1 November 2022
1,227



At 31 October 2023

1,227



Depreciation


At 1 November 2022
614


Charge for the year on owned assets
307



At 31 October 2023

921



Net book value



At 31 October 2023
306

Page 6

 
GKO MEDICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2023

5.


Debtors

2023
2022
£
£


Trade debtors
26,840
5,707

Amounts owed by joint ventures and associated undertakings
300,000
200,000

Other debtors
-
35

326,840
205,742



6.


Creditors: Amounts falling due within one year

2023
2022
£
£

Other taxation and social security
30,174
36,719

Other creditors
2,477
5,975

Accruals and deferred income
2,749
2,090

35,400
44,784



7.


Share capital

2023
2022
£
£
Allotted, called up and fully paid



35  'A' Ordinary shares of £1.00 each
35
35
35  'B' Ordinary shares of £1.00 each
35
35
10  'C' Ordinary shares of £1.00 each
10
10
10  'D' Ordinary shares of £1.00 each
10
10
10  'E' Ordinary shares of £1.00 each
10
10

100

100


8.


Related party transactions

As at 31 October 2023 the balance owed to the directors by the company was £2,477.

 
Page 7